Quantitative measurement of HER2 levels by multiplexed mass spectrometry to predict survival in gastric cancer patients treated with trastuzumab.

被引:0
|
作者
Ock, Chan-Young
An, Eunkyung
Oh, Do-Youn
Kim, Tae-Yong
Lee, Kyung-Hun
Han, Sae-Won
Im, Seock-Ah
Kim, Tae-You
Liao, Wei-Li
Cecchi, Fabiola
Blackler, Adele
Thyparambil, Sheeno P.
Hoos, William Arthur
Kim, Woo Ho
Burrows, Jon
Hembrough, Todd A.
Bang, Yung-Jue
机构
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] OncoPlex Diagnost, Rockville, MD USA
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Canc Res Inst, Seoul 151, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
关键词
D O I
10.1200/jco.2015.33.15_suppl.4050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4050
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
    Zhou, Jun
    Peng, Zhi
    Liu, Yi
    Gong, Jifang
    Zhang, Xiaotian
    Lu, Ming
    Gao, Jing
    Li, Yili
    Li, Yanyan
    Shen, Lin
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 955 - 961
  • [32] Correlation of high levels of HER2 measured by multiplex mass spectrometry with increased overall survival in patients treated with anti-HER2-based therapy.
    Nuciforo, Paolo
    Thyparambil, Sheeno P.
    Garrido-Castro, Ana Christina
    Peg, Vicente
    Prudkin, Ludmila
    Jimenez, Jose
    Hoos, William Arthur
    Burrows, Jon
    Hembrough, Todd A.
    Perez-Garcia, Jose Manuel
    Cortes, Javier
    Scaltriti, Maurizio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] The use of ErbB/HER activation status as prognostic markers in breast cancer patients treated with trastuzumab.
    Mukherjee, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 17S - 17S
  • [34] Quantitative Analysis of HER2 Amplification by Droplet Digital PCR in the Follow-Up of Gastric Cancer Patients Being Treated with Trastuzumab after Surgery
    Liu, Yanzhuo
    Yang, Maozhu
    Jiang, Tao
    Lan, Chunbin
    Yuan, Hao
    Li, Guiquan
    Jia, Guiqing
    Wang, Kang
    Zhao, Gaoping
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [35] Droplet digital PCR measurement of HER2 in patients with gastric cancer
    H Kinugasa
    K Nouso
    T Tanaka
    K Miyahara
    Y Morimoto
    C Dohi
    T Matsubara
    H Okada
    K Yamamoto
    British Journal of Cancer, 2015, 112 : 1652 - 1655
  • [36] Droplet digital PCR measurement of HER2 in patients with gastric cancer
    Kinugasa, H.
    Nouso, K.
    Tanaka, T.
    Miyahara, K.
    Morimoto, Y.
    Dohi, C.
    Matsubara, T.
    Okada, H.
    Yamamoto, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (10) : 1652 - 1655
  • [37] Droplet digital PCR measurement of HER2 in patients with gastric cancer
    Kinugasa, Hideaki
    Nouso, Kazuhiro
    Tanaka, Takehiro
    Miyahara, Koji
    Morimoto, Yuki
    Dohi, Chihiro
    Okada, Hiroyuki
    Yamamoto, Kazuhide
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 14 - 14
  • [38] Factors influencing survival of 107 HER2 positive breast cancer patients treated with trastuzumab based neoadjuvant chemotherapy
    Favier, L.
    Guiu, S.
    Dunach, E.
    Assous, D.
    Bonnetain, F.
    Gligorov, J.
    Stockmeier, V.
    Vasseur, B.
    Fumoleau, P.
    Coudert, B.
    EJC SUPPLEMENTS, 2007, 5 (04): : 201 - 201
  • [39] Exploratory analysis of HER2 extracellular domain in HER2-positive gastric cancer treated with SOX plus trastuzumab
    Hironaka, Shuichi
    Wakatsuki, Takeru
    Ishizuka, Naoki
    Minashi, Keiko
    Kadowaki, Shigenori
    Goto, Masahiro
    Shoji, Hirokazu
    Hirano, Hidekazu
    Nakayama, Izuma
    Osumi, Hiroki
    Ogura, Mariko
    Chin, Keisho
    Yamaguchi, Kensei
    Takahari, Daisuke
    ANNALS OF ONCOLOGY, 2022, 33 : S498 - S498
  • [40] PROGNOSTIC IMPACT OF HER2 IMMUNOREACTIVITY IN HER2-POSITIVE GASTRIC CANCER TREATED WITH TRASTUZUMAB-BASED CHEMOTHERAPY
    Kadowaki, Shigenori
    Narita, Yukiya
    Komori, Azusa
    Nomura, Motoo
    Taniguchi, Hiroya
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Niwa, Yasumasa
    Muro, Kei
    ANNALS OF ONCOLOGY, 2014, 25